蔚蓝生物
(603739)
| 流通市值：39.50亿 | | | 总市值：39.50亿 |
| 流通股本：2.53亿 | | | 总股本：2.53亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 215,679,228.18 | 197,646,686.12 | 229,768,103.37 | 248,727,434.36 |
| 交易性金融资产 | 223,095,833.41 | 152,573,443.56 | 242,241,107.86 | 199,344,169.54 |
| 应收票据及应收账款 | 420,671,617.34 | 389,385,929.1 | 357,309,295.28 | 370,220,614.48 |
| 其中：应收票据 | 12,601,553.03 | 10,593,644.22 | 3,668,705.76 | 19,793,517.34 |
| 应收账款 | 408,070,064.31 | 378,792,284.88 | 353,640,589.52 | 350,427,097.14 |
| 应收款项融资 | 4,090,838.44 | 2,487,677.96 | 5,963,067.58 | 6,360,832.3 |
| 预付款项 | 24,493,513.92 | 29,054,134.61 | 18,950,155.75 | 13,893,639.38 |
| 其他应收款合计 | 40,168,264.51 | 36,708,547.1 | 29,133,503.05 | 28,681,828.45 |
| 其中:应收利息 | - | - | 35,353.5 | - |
| 存货 | 216,743,499.06 | 223,601,915.3 | 194,098,570.42 | 188,950,475.37 |
| 其他流动资产 | 4,344,485.39 | 6,326,528.97 | 24,097,417.89 | 13,015,733.92 |
| 流动资产合计 | 1,149,287,280.25 | 1,037,784,862.72 | 1,101,561,221.2 | 1,069,194,727.8 |
| 非流动资产: | | | | |
| 债权投资 | 14,000,000 | 14,000,000 | 14,000,000 | 14,000,000 |
| 长期股权投资 | 74,588,849.7 | 78,906,754.6 | 78,768,001.46 | 78,644,384.47 |
| 其他权益工具投资 | 5,996,056.64 | 5,996,056.64 | 5,996,056.64 | 5,996,056.64 |
| 固定资产 | 1,305,439,872.53 | 1,324,933,354.46 | 1,348,633,937.3 | 1,356,420,830.54 |
| 在建工程 | 216,297,114.23 | 196,175,977.7 | 177,856,184.32 | 203,810,847 |
| 无形资产 | 127,322,169.05 | 127,271,049.48 | 130,100,589.4 | 131,127,990.79 |
| 商誉 | 84,202,475.98 | 84,202,475.98 | 84,202,475.98 | 84,202,475.98 |
| 长期待摊费用 | 1,601,111.63 | 1,967,568.21 | 1,831,756.45 | 1,472,939.8 |
| 递延所得税资产 | 22,485,648.3 | 21,528,375.21 | 16,712,721.93 | 16,989,786.03 |
| 其他非流动资产 | 40,311,096.6 | 56,053,430.93 | 65,539,726.95 | 19,140,517.14 |
| 非流动资产合计 | 1,892,244,394.66 | 1,911,035,043.21 | 1,923,641,450.43 | 1,911,805,828.39 |
| 资产总计 | 3,041,531,674.91 | 2,948,819,905.93 | 3,025,202,671.63 | 2,981,000,556.19 |
| 流动负债: | | | | |
| 短期借款 | 608,520,498.24 | 571,681,805.76 | 642,866,997.78 | 581,633,655.82 |
| 应付票据及应付账款 | 204,134,141.47 | 216,405,932.73 | 200,763,616.7 | 224,558,653.92 |
| 其中：应付票据 | 2,563,600 | 5,909,000 | 13,236,054.45 | 12,833,364.45 |
| 应付账款 | 201,570,541.47 | 210,496,932.73 | 187,527,562.25 | 211,725,289.47 |
| 预收款项 | - | - | 18,885,787.01 | - |
| 合同负债 | 16,292,675.77 | 19,147,689.49 | 288,679.25 | 11,509,541.7 |
| 应付职工薪酬 | 32,986,478.66 | 27,575,452.25 | 18,031,318.89 | 37,448,333.07 |
| 应交税费 | 18,581,548.98 | 9,890,102.88 | 11,443,084.39 | 18,850,355.74 |
| 其他应付款合计 | 113,819,047.66 | 106,938,882.79 | 107,350,445.42 | 106,632,848.52 |
| 应付股利 | - | 5,200,000 | - | - |
| 一年内到期的非流动负债 | 62,320,325.15 | 59,856,437.56 | 39,950,000 | 40,026,764.1 |
| 其他流动负债 | 6,691,116.21 | 5,603,127.16 | 17,488,409.08 | 10,789,141.94 |
| 流动负债合计 | 1,063,345,832.14 | 1,017,099,430.62 | 1,057,068,338.52 | 1,031,449,294.81 |
| 非流动负债: | | | | |
| 长期借款 | 13,806,437.56 | 6,520,325.15 | 25,703,526.81 | 13,956,437.56 |
| 长期应付款 | - | 152,000 | 152,000 | 152,000 |
| 递延收益 | 60,841,342.45 | 63,817,095.38 | 61,598,910.73 | 63,969,750.6 |
| 递延所得税负债 | 2,335,958.81 | 2,399,976.08 | 2,653,677.99 | 1,456,775.61 |
| 非流动负债合计 | 76,983,738.82 | 72,889,396.61 | 90,108,115.53 | 79,534,963.77 |
| 负债合计 | 1,140,329,570.96 | 1,089,988,827.23 | 1,147,176,454.05 | 1,110,984,258.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 253,028,866 | 253,028,866 | 253,028,866 | 253,028,866 |
| 资本公积 | 702,898,795.16 | 702,898,795.16 | 702,876,454.13 | 702,898,795.16 |
| 其他综合收益 | -15,273,966.11 | -15,238,486.82 | -15,131,591.87 | -15,104,131.8 |
| 盈余公积 | 56,085,169.04 | 56,085,169.04 | 56,085,169.04 | 56,085,169.04 |
| 未分配利润 | 777,288,145.15 | 742,225,288.16 | 750,388,709.33 | 740,811,881.65 |
| 归属于母公司股东权益合计 | 1,774,027,009.24 | 1,738,999,631.54 | 1,747,247,606.63 | 1,737,720,580.05 |
| 少数股东权益 | 127,175,094.71 | 119,831,447.16 | 130,778,610.95 | 132,295,717.56 |
| 股东权益合计 | 1,901,202,103.95 | 1,858,831,078.7 | 1,878,026,217.58 | 1,870,016,297.61 |
| 负债和股东权益合计 | 3,041,531,674.91 | 2,948,819,905.93 | 3,025,202,671.63 | 2,981,000,556.19 |
| 公告日期 | 2025-10-29 | 2025-08-28 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |